AdvaMed

MedTech Innovator Announces Top 50 Startups Selected for the 2022 Cohort in Tenth Year of World’s Largest MedTech Accelerator Program

Retrieved on: 
Tuesday, June 7, 2022
Professional Services, Health, Medical Devices, Other Health, Finance, General Health, Consulting, Cohort, Program, Conference, CEO, Accelerator, Medtech, AdvaMed, Industry, The, Grand final, Pharmaceutical industry, Video game

As 2022 Cohort members, these startups will get unparalleled visibility and access to leading medtech manufacturers, providers, investors, and other industry stakeholders.

Key Points: 
  • As 2022 Cohort members, these startups will get unparalleled visibility and access to leading medtech manufacturers, providers, investors, and other industry stakeholders.
  • The tenth annual program launches June 15-16, at the invite only MedTech Innovator Summit in Mountain View, California.
  • Leadership teams from each of the 50 startups will convene to attend networking events and workshops with MedTech Innovator Partners and other industry leaders.
  • An audience vote will determine the winner of the $350,000 non-dilutive grand prize and the title of 2022 MedTech Innovator.

PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO

Retrieved on: 
Friday, May 13, 2022
Science, Health, Research, Medical Devices, Risk, AdvaMed, ResMed, Test, Harvard University, U.S. Securities and Exchange Commission, Nasdaq, Patient, IEEE Medal for Innovations in Healthcare Technology, Carpal tunnel syndrome, Mount Sinai Medical Center, COVID-19, Esophageal cancer, Research, Industry, Academic health science centre, Facebook, Time, Intention, YouTube, Instagram, Forward-looking statement, Communication, Technology, Organization, Faculty, Chief executive officer, Therapy, LinkedIn, Twitter, Security (finance), Harvard Medical School, Medtronic, Annual report, CEO, Pharmaceutical industry, Medical device, Physics, Lucid, Part Two

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage cancer prevention medical diagnostics company, today announced that PAVmed and Lucid Chairman & Chief Executive Officer Lishan Aklog, M.D.

Key Points: 
  • PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage cancer prevention medical diagnostics company, today announced that PAVmed and Lucid Chairman & Chief Executive Officer Lishan Aklog, M.D.
  • was selected as one of the Top 50 Healthcare Technology CEOs of 2022 by The Healthcare Technology Report .
  • The Healthcare Technology Report described this years awardees as some of the most cultivated, intelligent executives in the healthcare and technology industry.
  • Dr. Lishan Aklog is Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a diversified, commercial-stage medical technology company which he co-founded, and its majority-owned subsidiary Lucid Diagnostics Inc., a cancer prevention medical diagnostics company (Nasdaq: LUCD).

Modulim Announces Appointment of Healthcare Technology Industry Veteran Carl St. Bernard to Board of Directors

Retrieved on: 
Tuesday, May 10, 2022
Cloud, Board, AdvaMed, Economics, Board of directors, Standard of care, Lifecell, GE Healthcare, Kidney disease, Company, Moyamoya disease, CA, Johnson & Johnson, Patient, Organization, BA, Diabetes, Leadership, Pepperdine University, Health, Marketing, Lafayette College, MBA, CEO, Technology, Multimedia, Hospital, Management

IRVINE, Calif., May 10, 2022 /PRNewswire/ -- Modulim, a health technology company that delivers point of care microvascular insight to save limbs and lives announces the appointment of Carl St. Bernard to its Board of Directors.

Key Points: 
  • IRVINE, Calif., May 10, 2022 /PRNewswire/ -- Modulim, a health technology company that delivers point of care microvascular insight to save limbs and lives announces the appointment of Carl St. Bernard to its Board of Directors.
  • Mr. St. Bernard has over 25 years of experience in medical technology leadership across a wide range of areas including vascular and medical imaging.
  • Modulim Announces Appointment of Healthcare Technology Industry Veteran Carl St. Bernard to Board of Directors
    "We are very pleased to welcome Carl to our Board," said Charlie Huiner, Chief Executive Officer of Modulim.
  • "Carl has an impressive track record of board experience and executive leadership in a range of start-up and established medical technology organizations in growth stages.

Former FDA CDRH Director, Office of Compliance, Joins NDA Partners as Expert Consultant

Retrieved on: 
Wednesday, April 13, 2022
Center for Drug Evaluation and Research, NDA, United States Department of Justice, Compliance, Biotechnology, Pharmacokinetics, Device, Toxicology, University, CDER, Center, JD, Food, FDA Center for Devices and Radiological Health, Leadership, Associate, Program, United States Congress Office of Compliance, Justice, Federal Trade Commission, CMC, Law, State of Illinois v. Alice Wynekoop, Food and Drug Administration, Policy, FDA, Industry, USP, CDRH, AdvaMed, University of Michigan, Association, Partner, Medical device, Research

WASHINGTON, April 13, 2022 /PRNewswire-PRWeb/ -- NDA Partners General Manager, Eric Fish, announced today that Steve Silverman, former Office of Compliance Director in FDA's CDRH, has joined the company as an Expert Consultant. Mr. Silverman's professional experience includes two decades in federal service including Director-level positions in FDA's Offices of Compliance in CDRH and the Center for Drug Evaluation and Research (CDER). There, he led quality and compliance initiatives, regulatory implementation, policy development, and public communications about medical devices and drugs. Mr. Silverman began his FDA service as an Associate Chief Counsel, where he handled legal actions against medical device and pharmaceutical companies. His professional experience also includes positions with the US Department of Justice, Federal Trade Commission, and AdvaMed, a medical device trade association.

Key Points: 
  • NDA Partners General Manager, Eric Fish, announced today that Steve Silverman, former Office of Compliance Director in FDA's Center for Devices and Radiological Health (CDRH), has joined the company as an Expert Consultant.
  • WASHINGTON, April 13, 2022 /PRNewswire-PRWeb/ -- NDA Partners General Manager, Eric Fish, announced today that Steve Silverman , former Office of Compliance Director in FDA's CDRH, has joined the company as an Expert Consultant.
  • Mr. Silverman began his FDA service as an Associate Chief Counsel, where he handled legal actions against medical device and pharmaceutical companies.
  • Services include product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management.

Dentsply Sirona Announces Appointment of Mr. John P. Groetelaars as New Board Member

Retrieved on: 
Wednesday, April 6, 2022
Guidant, Company, Forbes, AdvaMed, Organization, Non-executive director, Leadership, XRAY, Marketing, United Kingdom, C. R. Bard, Board, Patient, Boston Scientific, Sirona, CEO, Board of directors, Health, Medtech, Eli Lilly, Nasdaq, Becton, Dickinson and Company headquarters, GLOBE, The Advisory Board Company, Solution, Acquisition, Management, Hillrom, Davol Rubber Company

CHARLOTTE, N.C., April 06, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (Dentsply Sirona) (Nasdaq: XRAY)today announced that Mr. John P. Groetelaars has been appointed to its Board of Directors (the Board), increasing the size of its Board from eleven to twelve members.

Key Points: 
  • CHARLOTTE, N.C., April 06, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (Dentsply Sirona) (Nasdaq: XRAY)today announced that Mr. John P. Groetelaars has been appointed to its Board of Directors (the Board), increasing the size of its Board from eleven to twelve members.
  • We are pleased to welcome John Groetelaars to the Dentsply Sirona Board of Directors, said Eric K. Brandt, Non-Executive Chairman of the Board.
  • Johns deep medical technology experience and leadership roles will be a valuable addition to our Board of Directors.
  • Mr. John P. Groetelaars served as President, CEO and a Board member at Hillrom from May 2018 until the companys acquisition by Baxter International, Inc., in December 2021.

Integer Announces Board Leadership Transition

Retrieved on: 
Thursday, March 17, 2022
GLOBE, Corporate governance, Greatbatch, Patient, Board of directors, MDO, Director, Â, Integer, AdvaMed, Board, Company, Leadership, Chairperson, CEO, Toronto Organizing Committee for the 2015 Pan and Parapan American Games, Committee, NYSE, Management

Commensurate with this carefully planned transition, the Board of Directors plans to appoint current long-standing Integer Board member Pamela G. Bailey to serve as the next Chair of the Board.

Key Points: 
  • Commensurate with this carefully planned transition, the Board of Directors plans to appoint current long-standing Integer Board member Pamela G. Bailey to serve as the next Chair of the Board.
  • On behalf of the Integer Board of Directors, I wish to thank Billfor his immense contribution and insightful leadership over the past 22 years serving on the Integer Board, including his 14 years as Board Chair, said Joe Dziedzic, Integers President and CEO.
  • Bill has positioned the company to continue executing our strategy to deliver sustained outperformance and laid the groundwork for a smooth Board Chair transition.
  • Since joining the Integer Board in 2002, Pam has been an integral part of developing the strategic direction of Integer.

Heart Valve Voice US Announces Major Initiatives for Valve Disease Day Including My Valve My Voice Community App, Caregiver Event

Retrieved on: 
Tuesday, February 15, 2022
Other Health, Software, Managed Care, Mobile, Wireless, General Health, Internet, Philanthropy, Technology, Foundation, Clinical Trials, Cardiology, Health, American Heart Month, Human voice, Collection, Patient, Surgeon, Chairperson, National Heart Valve Disease Awareness Day, TAVR, Antidote, AdvaMed, Clinical trial, Android, DNP, Cardiovascular disease, IOS, Board, Partnership, Patient engagement in Canada, Senior, FACC, Payment, Associate, Caregiver, Cardiology, Focus, Executive, Medical imaging, Residential care, Pharmaceutical industry

Heart Valve Voice US, a nonprofit patient advocacy organization, is launching a new mobile app for its popular My Valve My Voice patient community.

Key Points: 
  • Heart Valve Voice US, a nonprofit patient advocacy organization, is launching a new mobile app for its popular My Valve My Voice patient community.
  • The app, now available for iOS and Android users, is among several initiatives for American Heart Month and Valve Disease Day announced today by the organization.
  • As part of a virtual conference on Valve Disease Day, February 22, Heart Valve Voice US is conducting a webinar focused on the importance of care partner support titled "Navigating the Patient/Care Partner Journey."
  • Heart Valve Voice US, a nonprofit patient advocacy organization, provides a united voice for people living with heart valve disease.

Healthcare Ready Announces 2021 “Heroes of the Supply Chain”

Retrieved on: 
Tuesday, February 15, 2022
Medical Devices, Medical Supplies, Public Policy, Government, Philanthropy, White House, Federal Government, State, Local, General Health, Pharmaceutical, Health, Foundation, Health, Patient, Becton, Syringe, Supply, Company, Federation, Regeneron Pharmaceuticals, Pandemic, AdvaMed, Vaccine, Nursing, Emergency, Awareness, Organization, Therapy, U.S. Department of Defense Strategy for Operating in Cyberspace, COVID-19 vaccine, Pharmacist, Becton, Dickinson and Company headquarters, HDA, Health care, Twitter, Pharmacy, Needle, Partnership, Wildfire, Lists of disasters, Human services, Physician, Industry, Coronavirus, Personal protective equipment, COVID-19, Vaccination, Disaster, Community, Office of Inspector General, U.S. Department of Health and Human Services, Pharmaceutical industry, Healthcare

Healthcare Ready , a national nonprofit organization working with public/private partners to strengthen the resiliency of communities before, during, and after disasters, today announced its 2021 Heroes of the Supply Chain honorees.

Key Points: 
  • Healthcare Ready , a national nonprofit organization working with public/private partners to strengthen the resiliency of communities before, during, and after disasters, today announced its 2021 Heroes of the Supply Chain honorees.
  • Healthcare Ready is pleased to honor key sectors of the supply chain as Heroes of the Supply Chain for their herculean efforts to quickly adapt, pivot, and innovate to fulfill the needs of the healthcare system and patients they serve during an incredibly challenging year, said Courtney Romolt, Programs Manager of Healthcare Ready.
  • Its why Healthcare Ready has named Regeneron, a leading biotechnology company, as one of our 2021 Heroes of the Supply Chain.
  • Through its Heroes of the Supply Chain initiative, on an annual basis, Healthcare Ready recognizes sectors of the healthcare supply chain who have gone above and beyond to ensure patients and providers have the supplies, medications, sanitization products, and personal protective equipment during emergencies.

Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference

Retrieved on: 
Monday, December 20, 2021
Twitter, GLOBE, Communication, LinkedIn, Conference, Surgeon, Standard of care, AdvaMed, NASDAQ, Wurmlingen, Private Securities Litigation Reform Act, Industry, U.S. Securities and Exchange Commission, SEC, Patient

A recording of the Companys presentation will be available Monday, January 10, 2022 at 7am ET.

Key Points: 
  • A recording of the Companys presentation will be available Monday, January 10, 2022 at 7am ET.
  • To access please visit the investor relations page of the Companys website at surgalign.com/investors/ .
  • Replays of the webcasts will be archived on the website for approximately 90 days.
  • Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors.

Orthofix Announces Appointment of Thomas A. West to Board of Directors

Retrieved on: 
Tuesday, December 14, 2021
FDA, Health, Medical Devices, Wendell Pritchett, Director, Company, Spine, Compensation, Board, Securities Act of 1933, Princeton University, Intersection, Securities Exchange Act of 1934, Joint Center for Political and Economic Studies, Intersect ENT, Business development, Worldwide, Wharton School of the University of Pennsylvania, Ear, NASDAQ, Risk, SEC, Medtronic, CEO, AdvaMed, Nose, Economics, Johnson & Johnson, Terminology, Chairperson, Multimedia, ENT, University, XENT, Division, Hologic, Management, Risk management, Marketing, Politics

West has been named to the Companys Board of Directors and appointed to the Compensation and Talent Development Committee.

Key Points: 
  • West has been named to the Companys Board of Directors and appointed to the Compensation and Talent Development Committee.
  • West named to Orthofix Board of Directors and appointed to the Compensation and Talent Development Committee.
  • Tom joins the Orthofix Board of Directors with more than 30 years of global experience in the medical device industry, said Catherine Burzik, Chair of the Board.
  • We feel his vast experience will benefit Orthofix by providing international and domestic insights and guidance as we grow globally.